Novo shares have surged greater than 20% amid oral Wegovy’s quick begin. Elsewhere, Terns opened up room for a possible partnership and Corcept solidified its case for an ovarian most cancers drug.
Elevate your perspective with NextTech Information, the place innovation meets perception.
Uncover the newest breakthroughs, get unique updates, and join with a world community of future-focused thinkers.
Unlock tomorrow’s traits at present: learn extra, subscribe to our e-newsletter, and turn into a part of the NextTech neighborhood at NextTech-news.com
